The rationale for the current experiment was based on previous research that has reported longer MAEs in migraine and other research showing impaired contrast sensitivity.
10,13,14,30 In line with the predictions, the MAE in the migraine group lasted longer than in the control group and low contrast test displays produced the longest MAEs in both groups. Significant group and interaction effects confirmed this; however, the significant group difference was only found in the second analysis (ANCOVA) when contrast sensitivity was added as a covariate. Contrary to previous research,
14,27,29,30 and to what had been predicted, there was no statistically significant difference between the control and migraine groups in contrast sensitivity. There was, nevertheless, a trend for the migraine group to have higher contrast thresholds, that is, they needed higher contrasts to be able to see the gratings, and contrast sensitivity significantly predicted MAE duration. This study has, therefore, replicated the trends for group differences in CLCG contrast sensitivity described previously
14 (Michelson contrast thresholds, migraine: 0.3 ± 0.2, control: 0.2 ± 0.1; here, migraine 0.4 ± 0.3, control 0.3 ± 0.1). As regards the MAE data, Shepherd
13 used the same adaptation and test display contrast conditions (random dot adapting and test displays, Michelson contrast 30%) and reported comparable results for the group differences presented here: longer MAEs in migraine versus control groups. Furthermore, the trend for impaired contrast sensitivity to be associated with poorer performance on relative motion, motion detection, and motion discrimination tasks
14 also is consistent with the data reported here whereby poorer contrast sensitivity, likely arising from processing in early visual pathways (see prior study
34), is associated with an impoverished/shorter perception of motion in the duration of the MAE.